SEC Form 4 · accession 0001437749-26-030334
NATIONAL HEALTHCARE CORP · NHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Josh A McCreary
Officer — Senior VP & General Counsel
Period of report
Sep 10, 2026
Accepted (ET)
Sep 14, 2026 · 4:36 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001047335
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 10, 2026 | S | 571 | $222.7342 | D | 12,127 | D | |
| Common StockF2 | Sep 10, 2026 | S | 789 | $223.778 | D | 11,338 | D | |
| Common StockF3 | Sep 10, 2026 | S | 1,291 | $225.087 | D | 10,047 | D | |
| Common StockF4,F5 | Sep 10, 2026 | S | 68 | $225.5863 | D | 9,979 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $53.94 | holding | — | — | — | Mar 8, 2024 | Mar 8, 2028 | Common Stock | 4,000 | 4,000 | D |
| Option to Purchase Common Stock | $94.10 | holding | — | — | — | Mar 5, 2025 | Mar 5, 2029 | Common Stock | 8,000 | 8,000 | D |
| Option to Purchase Common Stock | $90.62 | holding | — | — | — | Feb 24, 2026 | Feb 24, 2030 | Common Stock | 9,000 | 9,000 | D |
| Option to Purchase Common Stock | $157.13 | holding | — | — | — | Feb 23, 2027 | Feb 23, 2031 | Common Stock | 14,000 | 14,000 | D |
Explanation of responses
- F1The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.31 to $223.21, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- F2The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.35 to $224.15, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- F3The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.56 to $225.515, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- F4The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.565 to $225.60, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- F5Total amount of shares beneficially owned following transactions reported on this form.